Picture of Neuropace logo

NPCE Neuropace Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m-13.52%
3m+39.7%
6m+45.88%
1yr+168.14%
Volume Change (%)
10d/3m-2.42%
Price vs... (%)
52w High-23.47%
50d MA-5.79%
200d MA+57.66%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-29.72%
Return on Equity-118.91%
Operating Margin-41.54%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Neuropace EPS forecast chart

Profile Summary

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorder.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
November 19th, 1997
Public Since
April 22nd, 2021
No. of Shareholders
186
No. of Employees
171
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Market
Shares in Issue
28,344,637

NPCE Share Price Performance

Upcoming Events for NPCE

Q1 2024 Neuropace Inc Earnings Release

Neuropace Inc Annual Shareholders Meeting

Q2 2024 Neuropace Inc Earnings Release

Similar to NPCE

Picture of 908 Devices. logo

908 Devices.

us flag iconNASDAQ Global Market

Picture of Alpha Teknova logo

Alpha Teknova

us flag iconNASDAQ Global Market

Picture of AtriCure logo

AtriCure

us flag iconNASDAQ Global Market

Picture of Brainsway logo

Brainsway

us flag iconNASDAQ Global Market

Picture of Castle Biosciences logo

Castle Biosciences

us flag iconNASDAQ Global Market

FAQ